Claudio Bertuccioli

Plus aucun poste en cours

Profil

Dr. Bertuccioli brings to ABV many years of professional experience in life sciences, first as an academic research biologist, then as a venture capitalist.
Prior to joining ABV, he was a Principal with Rho Ventures, a $1.2 billion VC firm with a broadly diversified portfolio of healthcare and technology companies, where he was responsible for primary deal screening and due diligence for healthcare investments.
During his time with Rho, he invested $175 million into more than 20 biotech and medical technology startups and achieved a number of successful IPOs and exits.
Prior to Rho, Dr. Bertuccioli gained investment experience with Atlas Ventures in Boston and as a co-founder of Dwarf, an Internet-focused angel investment fund in New York.
He started his career in finance as a management consultant with Oliver, Wyman & Co., a strategic management consultancy focused on the financial services industry.
Dr. Bertuccioli began his professional career as a molecular biologist studying the function of genes involved in early embryonic development.
Following a B.A.
with 1st class honors from Cambridge University in molecular biology and genetics, Dr. Bertuccioli completed a Ph.D.
in molecular biology and embryology at The Rockefeller University, where he was the recipient of research funding from the Howard Hughes Medical Institute.

Anciens postes connus de Claudio Bertuccioli

Sociétés	Poste	Fin
ABV LLC	Corporate Officer/Principal	30/03/2010
Rho Capital Partners, Inc.	Corporate Officer/Principal	-

Formation de Claudio Bertuccioli

University of Cambridge	Undergraduate Degree
The Rockefeller University	Doctorate Degree